Bibliographic Details
| Title: |
PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer Growth. |
| Authors: |
Campos Haedo, Mateo N.1 (AUTHOR) mateocamposhaedo@gmail.com, Díaz Albuja, Johanna A.1 (AUTHOR) johanna_diazalbuja@uca.edu.ar, Camarero, Sandra2 (AUTHOR) sandracamarero2@gmail.com, Cayrol, Florencia1 (AUTHOR) florencia_cayrol@uca.edu.ar, Sterle, Helena A.1 (AUTHOR) helena_sterle@uca.edu.ar, Debernardi, María M.1 (AUTHOR) mdebernardi@uca.edu.ar, Perona, Marina3,4 (AUTHOR) mperona@cnea.gov.ar, Saban, Melina5 (AUTHOR) msaban@hbritanico.com.ar, Ernst, Glenda6 (AUTHOR) GErnst@hbritanico.com.ar, Mendez, Julián7 (AUTHOR) jumendez@hbritanico.com.ar, Paulazo, María A.1 (AUTHOR) alejandra_paulazo@uca.edu.ar, Juvenal, Guillermo J.3,4 (AUTHOR) juvenal@cnea.gov.ar, Díaz Flaqué, María C.1 (AUTHOR) diazflaque@gmail.com, Cremaschi, Graciela A.1 (AUTHOR) graciela_cremaschi@uca.edu.ar, Rosemblit, Cinthia1 (AUTHOR) graciela_cremaschi@uca.edu.ar |
| Source: |
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p12158. 21p. |
| Subject Terms: |
*THYROID hormone receptors, *THYROID cancer, *TUMOR growth, *THYROID gland tumors, *IMMUNOHISTOCHEMISTRY |
| Abstract: |
Thyroid carcinoma (TC) is the most common endocrine neoplasia, with its incidence increasing in the last 40 years worldwide. The determination of genetic and/or protein markers for thyroid carcinoma could increase diagnostic precision. Accumulated evidence shows that Protein kinase C alpha (PKCα) contributes to tumorigenesis and therapy resistance in cancer. However, the role of PKCα in TC remains poorly studied. Our group and others have demonstrated that PKCs can mediate the proliferative effects of thyroid hormones (THs) through their membrane receptor, the integrin αvβ3, in several cancer types. We found that PKCα is overexpressed in TC cell lines, and it also appeared as the predominant expressed isoform in public databases of TC patients. PKCα-depleted cells significantly reduced THs-induced proliferation, mediated by the integrin αvβ3 receptor, through AKT and Erk activation. In databases of TC patients, higher PKCα expression was associated with lower overall survival. Further analyses showed a positive correlation between PKCα and genes from the MAPK and PI3K-Akt pathways. Finally, immunohistochemical analysis showed abnormal upregulation of PKCα in human thyroid tumors. Our findings establish a potential role for PKCα in the control of hormone-induced proliferation that can be explored as a therapeutic and/or diagnostic target for TC. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
